-
DiscoveryLet there be sight
Discovery -
DiscoveryResearchers aim to beat trick play by tumors with drug combo
Discovery -
DiscoveryA fresh look at fighting glaucoma
Ask Alan Frohman how he found out that he had glaucoma, and he'll quickly tell you that there were no warning signs.
Discovery -
DiscoveryCan we unlock the body's ability to regenerate lost hearing?
When a middle-aged firefighter and active Boy Scout leader in the Midwestern United States lost his hearing a few years ago, he also faced the loss of his livelihood.
Discovery -
DiscoveryBiological battle of the bulge
John Hadcock’s wife Laura gave him an ultimatum: Run the energy out of Sunny, the new puppy, or take her back to the breeder. So Hadcock started running. On his first trip out, he had to stop half a mile in.
Discovery -
DiscoveryNovartis researches SMA’s genetic roots
Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.
Discovery -
DiscoveryNovartis scientists target resistance threat in malaria
Novartis hopes to prevent, treat and block malaria and is conducting clinical trials to test some promising therapies. Learn more.
Discovery -
DiscoveryMutant protein spreads through a neural circuit in Huntington’s Disease
Read how a genetics postdoctoral researcher finds Huntington's mutation travels through neural circuits.
Discovery -
DiscoveryCancer cocktails come of age
Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.
Discovery -
DiscoveryCancer cocktails: LEE011 – a popular combination partner
Discovery -
DiscoveryCancer cocktails: ABL001 – hitting one target twice
Discovery -
DiscoveryNovartis antibody increases muscle growth in mice and human cell cultures
An antibody that boosts muscle mass could mean independence for the frail and elderly. Learn how Novartis research aims to improve healthy aging.
Discovery